Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Klaus Ueberla"'
Autor:
Andreas Beyerlein, Bernhard Liebl, Gabriele Hoelscher, Uta Nennstiel, Klaus Ueberla, Katharina Katz, Delphina Gomes, Ruediger von Kries
BackgroundThe effect of the BioNTech-Pfizer BNT162b2 vaccination in the elderly (≥80 years) could not be fully assessed in the BioNTech-Pfizer trial due to low numbers in this age group. We aimed to evaluate the effectiveness of the BioNTech-Pfizer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e433cc689019a5572e917447592d530
https://doi.org/10.1101/2021.08.19.21262266
https://doi.org/10.1101/2021.08.19.21262266
Autor:
Markus Hoffmann, Leila Issmail, Jana Fuchs, Thomas Grunwald, Andrea Cara, Anna Schmidt, Stefan Poehlmann, Torsten Willert, Matthias Tenbusch, Christian Thirion, Pascal Irrgang, Klaus Ueberla, Ana Vieira Antão, Valentina Everlein, Nadja Uhlig, Dennis Lapuente, Jonas Willar, Antonia Sophia Peter, Sandra Mueller-Schmucker, Armin Ensser, Friederike Oltmanns, Kirsten Fraedrich, Cordula Pertl
Several effective SARS-CoV-2 vaccines are currently in use, but in the light of waning immunity and the emergence of novel variants, effective boost modalities are needed in order to maintain or even increase immunity. Here we report that intranasal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f02bd2865da324745bc4b02c72bc7fd
https://doi.org/10.1101/2021.08.03.454858
https://doi.org/10.1101/2021.08.03.454858
Autor:
Pascal Irrgang, Ronja Brockhoff, Hrvoje Mijočević, Alina Priller, Christian Bogdan, Kathrin Tinnefeld, Juergen Held, Sofie Schumacher, Sarah Yazici, Matthias Tenbusch, Emanuel Vogel, Oliver A. Cornely, Klaus Ueberla, Ulrike Protzer, Kilian Schober, Philipp Steininger, Percy A. Knolle, Jon Salmanton-García, Stephanie Beileke
Administration of a first dose of the COVID-19 vaccine ChAdOx1 nCoV-19 (Vaxzevria®, AstraZeneca) is associated with a certain risk for vaccine-induced immune thrombotic thrombocytopenia. Therefore, several countries have recommended replacing the se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1e125db9773b5d7208e004d551c15c0
https://doi.org/10.1101/2021.07.03.21258887
https://doi.org/10.1101/2021.07.03.21258887
Autor:
Felix Guenther, Helmut Kuechenhoff, Antje Knoell, Michael Kabesch, Olaf Gefeller, Klaus Korn, Sebastian Einhauser, André Gessner, Hans-Helmut Niller, Ralf Wagner, Annette Pfahlberg, Matthias Tenbusch, Iris M. Heid, Klaus Stark, Ralph Burkhardt, Stephanie Beileke, Clara Maier, Melanie Berr, Philipp Steininger, Holger Schedl, David Peterhoff, Anja Schuetz, Klaus Ueberla
SARS-CoV-2 infection fatality ratios (IFR) remain controversially discussed with implications for political measures, but the number of registered infections depends on testing strategies and deduced case fatality ratios (CFR) are poor proxies for IF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3eb887da8657ef92a91446341bf191f
https://doi.org/10.1101/2021.03.29.21254343
https://doi.org/10.1101/2021.03.29.21254343
Autor:
Armin Ensser, Klaus Ueberla
Population density, behaviour and cultural habits strongly influence the spread of pathogens. Consequently, key epidemiological parameters may vary from country to country. Confirmed COVID-19 cases in in China have been used to estimate those paramet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d33a297bfa8f85a71503b1e28870269
Autor:
Hartmut Hengel, Edeltraut Garbe, Bernhard Ultsch, Klaus Ueberla, Judith Koch, Fred Zepp, Rüdiger von Kries, Thomas Ledig, Anette Siedler, Thomas Mertens
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 60:1162-1179
A live attenuated vaccine (Zostavax (R)) against herpes zoster (HZ) and posther-petic neuralgia (PHN) was licensed for persons 50 years of age and older in 2006 and became available in Germany in September 2013. Based on the conclusion, that an effec
Autor:
Tobias Engelhorn, Klaus Korn, Arnd Doerfler, Andreas Merkel, Udo S. Gaipl, Nicole L. Goerig, Manuel Schmidt, Bernhard Fleckenstein, Rainer Fietkau, I. Eyuepoglu, Sabine Semrau, Klaus Ueberla, F. Putz, Paul F Ruehle, Benjamin Frey
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:E75-E76
Autor:
Klaus Korn, Nicole L. Goerig, Arnd Doerfler, Udo S. Gaipl, Manuel Schmidt, Paul F Ruehle, Sabine Semrau, Florian Putz, Rainer Fietkau, Klaus Ueberla, Ilker Eyupoglus, Tobias Engelhorn, Benjamin Frey, Bernhard Fleckenstein
Publikováno v:
Neuro-oncology. 18(12)
Background Neurological decline during radio(chemo)therapy of the brain is often attributed to disease progression or side effects of radiotherapy. Diagnosis of opportunistic neurotropic infections such as cytomegalovirus (CMV) infections is uncommon
Autor:
Andreas Merkel, Nicole L. Goerig, Klaus Korn, Rainer Fietkau, Florian Putz, Ilker Y. Eyüpoglu, Tobias Engelhorn, Benjamin Frey, Arnd Doerfler, Sabine Semrau, Manuel Schmidt, Bernhard Fleckenstein, Klaus Ueberla, Udo S. Gaipl, Paul F Ruehle
Publikováno v:
Journal of Clinical Oncology. 35:2036-2036
2036 Background: As recently demonstrated (Neurooncology, 2016), neurological decline of patients with brain cancer (high grade glioma, brain metastases) during radio(chemo)therapy (RCT) of the brain is oftentimes caused by CMV-encephalopathy but not